Literature DB >> 2927653

Criteria for establishing the validity of genetic recombination in myotonic dystrophy.

R C Griggs1, D S Wood.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2927653     DOI： 10.1212/wnl.39.3.420

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  30 in total

Review 1.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

2.  Instability in the normal CTG repeat range at the myotonic dystrophy locus.

Authors:  A Meiner; B Thamm; S Strenge; U Froster
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

3.  Myotonic dystrophy health index: Correlations with clinical tests and patient function.

Authors:  Chad Heatwole; Rita Bode; Nicholas E Johnson; Jeanne Dekdebrun; Nuran Dilek; Katy Eichinger; James E Hilbert; Eric Logigian; Elizabeth Luebbe; William Martens; Michael P Mcdermott; Shree Pandya; Araya Puwanant; Nan Rothrock; Charles Thornton; Barbara G Vickrey; David Victorson; Richard T Moxley
Journal:  Muscle Nerve       Date:  2015-12-29       Impact factor: 3.217

4.  Use of variable simple sequence motifs as genetic markers: application to study of myotonic dystrophy.

Authors:  H J Smeets; H G Brunner; H H Ropers; B Wieringa
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

5.  Presymptomatic detection and prenatal diagnosis for myotonic dystrophy by means of linked DNA markers.

Authors:  A M Norman; J L Floyd; A L Meredith; P S Harper
Journal:  J Med Genet       Date:  1989-12       Impact factor: 6.318

6.  Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Authors:  E L Logigian; W B Martens; R T Moxley; M P McDermott; N Dilek; A W Wiegner; A T Pearson; C A Barbieri; C L Annis; C A Thornton; R T Moxley
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

7.  Direct molecular analysis of myotonic dystrophy in the German population: important considerations in genetic counselling.

Authors:  A Meiner; C Wolf; N Carey; A Okitsu; K Johnson; P Shelbourne; B Kunath; W Sauermann; H Thiele; P Kupferling
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

8.  Myotonic dystrophy: correlation of clinical symptoms with the size of the CTG trinucleotide repeat.

Authors:  A Jaspert; R Fahsold; H Grehl; D Claus
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

9.  D19S51 is closely linked with and maps distal to the myotonic dystrophy locus on 19q.

Authors:  C Tsilfidis; A E MacKenzie; G Shutler; S Leblond; J Bailly; K Johnson; R Williamson; J Siegel-Bartelt; R G Korneluk; P Shelbourne
Journal:  Am J Hum Genet       Date:  1991-11       Impact factor: 11.025

10.  Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM).

Authors:  H G Brunner; H T Brüggenwirth; W Nillesen; G Jansen; B C Hamel; R L Hoppe; C E de Die; C J Höweler; B A van Oost; B Wieringa
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.